Delivery Order SPE2DB22D3102-SPE2DB25FL2YC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Ceftriaxone 1 GM-D5W bags, a common broad-spectrum antibiotic used extensively in military and federal healthcare systems. This firm fixed price delivery order, valued at $9,528.22, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999 through...
- The Defense Logistics Agency awarded a $1,352.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ceftriaxone 2 GM-D5W bags, with an ultimate completion date of August 20, 2025. This award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded with no set-aside designation, and performance...
- The Defense Logistics Agency awarded a $18,599.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for Ceftriaxone 2 GM-D5W bags, with performance to be completed by September 5, 2025. This non-set-aside contract is a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is listed as Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Ceftriaxone 2 GM-D5W bags, a broad-spectrum antibiotic commonly used in military and federal healthcare systems. This firm fixed-price delivery order, valued at $5,353.10, is scheduled for completion by August 14, 2025, with performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,054.62 to AmerisourceBergen Drug Corp for the supply of Ceftriaxone 2 GM-D5W bags, with an ultimate completion date of July 31, 2025. This award was made on a firm fixed price basis with no set-aside designation, indicating competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $4,609.88 delivery order to AmerisourceBergen Drug Corp for Ceftriaxone 1 GM-D5W bags, with an ultimate completion date of August 15, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 5, 2025, for the supply of Ceftriaxone 1 GM-D5W bags with a ceiling value of $3,436.68. This firm fixed-price delivery order, which is expected to be completed by August 6, 2025, represents a competitively awarded, non-set-aside contract and will be performed at the contractor's Conshohocken facility. Ceftriaxone...
- The Defense Logistics Agency awarded a $2,268.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ceftriaxone 2 GM-D5W bags, with an ultimate completion date of August 4, 2025. This non-set-aside contract was awarded on August 1, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Ceftriaxone 2 GM-D5W bags, a common antibiotic medication used in military and federal healthcare systems. This firm fixed-price delivery order, valued at $2,890.58, represents a non-set-aside competitive award with an ultimate completion date of July 22, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $1,696.38 to AmerisourceBergen Drug Corp for the supply of Ceftriaxone 1 GM-D5W bags, a broad-spectrum antibiotic commonly used in military and federal healthcare settings. This competitively awarded, firm fixed-price delivery order was issued on August 12, 2025, with an ultimate completion date of August 13, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract carries no...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB25FL2YCDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Ceftriaxone 2 GM-D5W bags with a ceiling value of $1,977.90. This is a firm fixed price delivery order with no set-aside designation, reflecting competitive procurement practices. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as the prime vendor vehicle for pharmaceutical and medical supply support to military healthcare systems globally. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, particularly for Defense Health Agency and military healthcare operations. The delivery order for Ceftriaxone, a broad-spectrum antibiotic, exemplifies the company's role in supplying essential pharmaceutical products across multiple therapeutic domains. Performance of this delivery order will occur at the company's Conshohocken location, with completion scheduled for September 11, 2025. The IDC vehicle enables AmerisourceBergen to fulfill diverse federal medical supply requirements while maintaining operational efficiency across military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 9/10/25 |